ניטרודרם 10 tts
novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.
ניטרודרם tts 10
novartis israel ltd - glyceryl trinitrate - מדבקות - glyceryl trinitrate 50 mg/patch - glyceryl trinitrate - glyceryl trinitrate - prophylaxis of angina pectoris.
ניטרודרם 10 tts
novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.
ניטרודרם 10 tts
novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.
לופרסור דיויטבס 200 מג
novartis israel ltd - metoprolol tartrate - טבליות בשחרור איטי - metoprolol tartrate 200 mg - metoprolol - metoprolol - hypertension, angina pectoris, arrhythmia, prophylaxis of migrain, prophylaxis of reinfarction.
אקספורג' 5 מ"ג/ 320 מ"ג
novartis pharma services ag - amlodipine as besylate 5 mg; valsartan 320 mg - film coated tablets - valsartan - exforge ( amlodipine and valsartan) is insicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension.
אקספורג' 10 מ"ג/ 320 מ"ג
novartis pharma services ag - amlodipine as besylate 10 mg; valsartan 320 mg - film coated tablets - valsartan - exforge ( amlodipine and valsartan) is insicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension.
ראסילז 150 מ"ג
novartis pharma services ag - aliskiren 150 mg - film coated tablets - aliskiren - treatment of essential hypertension.
ראסילז 300 מ"ג
novartis pharma services ag - aliskiren 300 mg - film coated tablets - aliskiren - treatment of essential hypertension.
לסכול 20 מ"ג
novartis pharma services ag - fluvastatin as sodium 20 mg - capsules - fluvastatin - reduction of elevated levels of total cholesterol, ldl cholesterol, apolipoprotein b and triglycerides and increase of hdl cholesterol in patients with primary hypercholesterolemia and primary mixed dyslipidemia (fredrickson types iia and iib) in whom dietary measures have proved insufficiently effective.